Get the Weekly Intelligence Brief — top committee picks every Sunday.

CL vs CVSA

Colgate-Palmolive vs Covista Inc. — AI-powered side-by-side comparison
CL
Colgate-Palmolive
69
Insufficient Data
VS
CVSA
Covista Inc.
57
Watch
MetricCLCVSA
AI Score 69 57
Price $92.32 $125.97
P/E Ratio 36.29× 16.60×
ROE 3948.1% 17.4%
Revenue Growth YoY
Gross Margin 60.4% 57.3%
Debt / Equity 33.29× 0.63×
Dividend Yield 2.3% 0.0%
RSI (14) 56.5 48.4
Beta 0.322 0.623
Expected Upside +1.1%

AI Committee View

Current Innellis committee reasoning for CL versus CVSA.
CL leads by 12 points.

CL scores 69/100 (Insufficient Data) versus CVSA at 57/100 (Watch).

CL Committee View
100% agreement
3 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • Risk/reward is unfavorable: 2.5% downside vs 1.1% upside.
CVSA Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — current ratio of 0.82 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 16.6% shows genuine earnings power backing the valuation — Value
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Current ratio of 0.82 is tight -- limited short-term liquidity cushion — Risk
  • Bollinger bandwidth of 24.6% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CL Full Analysis CVSA Full Analysis